Larry (Lei) Xiao, Ph.D.
Chairman, Chief Executive Officer, and Chief Scientific Officer

Co-founder of Innovative Cellular Therapeutics.

Over 15 years’ experience studying CAR-T, stem cells and cell therapy.

Served as Professor and Doctoral supervisor at Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences of CAS, and Zhejiang University.

Completed postdoctoral training at The Johns Hopkins University; holds a Ph.D. from Ludwig-Maximilians Universität München.